Aviceda Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, focused on glyco-immune checkpoint therapeutics. The company develops…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Aviceda →Already a subscriber? Sign in
Xcout Intel tracks Aviceda continuously — this profile deepens as new filings, funding, people and hiring data arrive.